(Q33439923)

English

Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Antoine Pariente

object named as

Antoine Pariente

1

0 references

author name string

Amélie Daveluy

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Anne Laribière-Bénard

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ghada Miremont-Salame

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bernard Begaud

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nicholas Moore

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

441-447

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Spontaneous reporting of adverse drug reactions. I: the data

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932050-00007

21 January 2018

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932050-00007

21 January 2018

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932050-00007

21 January 2018

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous reporting of adverse drug reactions. II: Uses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessments of disproportionality

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous reporting of adverse drug reactions: who reports and what?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of spontaneous reporting of adverse drug reactions in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confounding by indication and channeling over time: the risks of beta 2-agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection, verification, and quantification of adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The drug therapy of depression with particular consideration of suicide prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COMPLICATIONS OF ANTIDEPRESSIVE TREATMENTS

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporal patterns of NSAID spontaneous adverse event reports: the Weber effect revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is reporting rate a good predictor of risks associated with drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disproportionality analyses of spontaneous reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reporting odds ratio and its advantages over the proportional reporting ratio

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attitudinal survey of voluntary reporting of adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporal trends in spontaneous reporting of unlabelled adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19419238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200932050-00007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33439923&oldid=2195364274"